Impact of Endothelial Cell Activation and Modifications of Haemostasis Induced by Infective Endocarditis on the Risk of Embolism

Assistance Publique Hopitaux De Marseille77 enrolled

Overview

Prospective study including all the consecutive patients admitted at the Department of Cardiology, Timone Hospital wih a definite diagnosis of IE according to the modified Duke criteria. The period of inclusion will be for 24 months. Eighty patients and age-matched control subject will be included. Primary end point are EE occurring during the antimicrobial treatment and secondary end points will be 6-month mortality, vegetation length and the impact of antimicrobial treatment on inflammation-induced procoagulant changes and endothelial cell activation.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Enrollment

Conditions

Infective Endocarditis

Interventions

ULTRASONOGRAPHY trans-esophageal and trans-thoracic , blood test and clinic test

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * All the patients presenting certain diagnosis of infectious endocardite according to the criteria of modified Duke Exclusion Criteria: * Age \< 18 years * Pregnancy and feeding * Health not allowing to give the assent * Innate abnormalities of the haemostasis * More than a week before the inclu antibiothérapie adapted begun

Outcomes

Primary Outcomes

Embolic events occurring during the antimicrobial treatment a

Time frame: 30 months

Secondary Outcomes

Will be 6-month mortality, vegetation length and the impact of antimicrobial treatment on inflammation-induced procoagulant changes and endothelial cell activation.

Time frame: 30months